GlaxoSmithKline aims to make 1B doses of vaccine booster for multiple COVID-19 partners

GlaxoSmithKline has penned deals offering its pandemic vaccine adjuvant to several developers of COVID-19 shots. And it needs to amp up supply for those companies to make enough doses of their final products.